http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106668723-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_459f485a5ec6c3a54cae33be63b1f746 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 |
filingDate | 2015-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6342d2ab932a750615dee22442456c30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2048c5336140e87990f4618e21363053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44c91f468ba6cf2f05d859538d462f1e |
publicationDate | 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106668723-A |
titleOfInvention | Esophageal and gastric cancer-restraining oral liquid as traditional Chinese medicine of Hui nationality and preparation method of esophageal and gastric cancer-restraining oral liquid |
abstract | The invention detailedly describes a formula and a preparation method of esophageal and gastric cancer-restraining oral liquid as a traditional Chinese medicine of the Hui nationality. The esophageal and gastric cancer-restraining oral liquid is a green high-tech Chinese herbal medicine for treating an esophageal cancer and a gastric cancer. The esophageal and gastric cancer-restraining oral liquid is a traditional Chinese medicine decoction prepared by mixing subprostrate sophora, rhizoma zedoariae, aralia elata, fructus akebiae and other Chinese herbal medicines according to a certain proportion, adding water, decocting, extracting and concentrating, is mainly used for treating the esophageal cancer and the gastric cancer and has the effect of treating a throat cancer, a colorectal cancer and other digestive system cancers. The esophageal and gastric cancer-restraining oral liquid described by the invention has the characteristics of being less in medicine taste and moderate in dosage; the selected medicines are proved to be able to treat the cancers by a modern pharmacological experiment; the esophageal and gastric cancer-restraining oral liquid fundamentally improves body functions at a low cost, and prevents and treats cancer cells, thereby restoring body health. |
priorityDate | 2015-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.